Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.
Purity:
96.50%
CAS Number:
[1855925-27-7]
Target:
Integrin|||Others
T76674
T76674
* VAT and and shipping costs not included. Errors and price changes excepted
